Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia:: a double-blind study (2004)
- Authors:
- USP affiliated authors: ELKIS, HELIO - FM ; GATTAZ, WAGNER FARID - FM
- Unidade: FM
- DOI: 10.1016/s0920-9964(03)00082-3
- Subjects: ESQUIZOFRENIA; MULHERES; GÊNEROS (GRUPOS SOCIAIS); ANTIPSICÓTICOS
- Language: Inglês
- Imprenta:
- Publisher place: Cincinnati
- Date published: 2004
- Source:
- Título do periódico: Schizophrenia Research
- ISSN: 0920-9964
- Volume/Número/Paginação/Ano: v. 66, p. 97-100, 2004
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LOUZÃ, Mario R. et al. Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia:: a double-blind study. Schizophrenia Research, v. 66, p. 97-100, 2004Tradução . . Disponível em: https://doi.org/10.1016/s0920-9964(03)00082-3. Acesso em: 24 abr. 2024. -
APA
Louzã, M. R., Marques, A. P., Elkis, H., Bassitt, D., Diegoli, M., & Gattaz, W. F. (2004). Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia:: a double-blind study. Schizophrenia Research, 66, 97-100. doi:10.1016/s0920-9964(03)00082-3 -
NLM
Louzã MR, Marques AP, Elkis H, Bassitt D, Diegoli M, Gattaz WF. Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia:: a double-blind study [Internet]. Schizophrenia Research. 2004 ; 66 97-100.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/s0920-9964(03)00082-3 -
Vancouver
Louzã MR, Marques AP, Elkis H, Bassitt D, Diegoli M, Gattaz WF. Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia:: a double-blind study [Internet]. Schizophrenia Research. 2004 ; 66 97-100.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/s0920-9964(03)00082-3 - Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol
- Decreased S100-beta protein in schizophrenia: preliminary evidence
- Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study
- Treatment of patients with recently exacerbated schizophrenia with paliperidone palmitate: a pilot study of efficacy and tolerability
- A double blind placebo controlled study of conjugated estrogens added to haloperidol in patients with schizophrenia
- Ventricular enlargement as a predictor of therapeutic response in schizophrenia: a structural MRI study
- Algumas recomendações para estudos com placebo
- Esquizofrenia e gênero
- Leonhard´s classification of Schizophrenias and MRI brain abnormalities: preliminary results
- Niacin test in schizophrenia and in major depression
Informações sobre o DOI: 10.1016/s0920-9964(03)00082-3 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
